Poolbeg Pharma Balance Sheet

Financials in millions GBP. Fiscal year is January - December.

Millions GBP. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021
Period Ending	Dec '23 Dec 31, 2023	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	12.17	12.17	16.19	20.95
Cash & Short-Term Investments	12.17	12.17	16.19	20.95
Cash Growth	-24.84%	-24.84%	-22.70%	-
Accounts Receivable	-	-	-	0.01
Other Receivables	0.66	0.66	0.08	0.05
Receivables	0.66	0.66	0.08	0.06
Prepaid Expenses	0.67	0.67	0.88	0.45
Total Current Assets	13.5	13.5	17.16	21.46
Other Intangible Assets	1.93	1.93	2.13	1.56
Total Assets	15.43	15.43	19.29	23.02
Accounts Payable	0.08	0.08	0.29	0.08
Accrued Expenses	0.9	0.9	0.67	0.36
Other Current Liabilities	0.01	0.01	0	0
Total Current Liabilities	0.99	0.99	0.97	0.44
Total Liabilities	0.99	0.99	0.97	0.44
Common Stock	0.1	0.1	0.1	0.1
Additional Paid-In Capital	23.1	23.1	23.1	23.1
Retained Earnings	-10.95	-10.95	-7.02	-2.34
Comprensive Income & Other	2.2	2.2	2.15	1.72
Shareholders' Equity	14.44	14.44	18.32	22.58
Total Liabilities & Equity	15.43	15.43	19.29	23.02
Net Cash (Debt)	12.17	12.17	16.19	20.95
Net Cash Growth	-24.84%	-24.84%	-22.70%	-
Net Cash Per Share	0.02	0.02	0.03	0.07
Filing Date Shares Outstanding	500	500	500	500
Total Common Shares Outstanding	500	500	500	500
Working Capital	12.51	12.51	16.19	21.02
Book Value Per Share	0.03	0.03	0.04	0.05
Tangible Book Value	12.51	12.51	16.19	21.02
Tangible Book Value Per Share	0.03	0.03	0.03	0.04

Source: S&P Capital IQ. Standard template. Financial Sources.